Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-054299
Filing Date
2019-10-28
Accepted
2019-10-28 21:46:15
Documents
1
Period of Report
2019-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1561
  Complete submission text file 0001209191-19-054299.txt   2994
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VANDA PHARMACEUTICALS INC. 2200 PENNSYLVANIA AVENUE, SUITE 300E WASHINGTON DC 20037
Business Address
Ward Anne Sempowski (Reporting) CIK: 0001790117 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34186 | Film No.: 191174327